10.1016/j.jpha.2023.07.001
Early cessation of GLP-1R agonists in individuals unlikely to experience any beneficial metabolic effects can reduce future probable adverse effects, enhance the risk/benefit ratio, and decrease the entire financial cost [118]
The initial feasibility testing conducted using Biobank samples has assessed the performance of the test in a cohort of 130 patients across multiple cancer types, including colorectal, prostate and breast
Notartomaso S, Mascio G, Bernabucci M, Zappulla C, Scarselli P, Cannella M, et al
Warning Signs to Watch For If you do choose to drink while on GLP-1 therapy, Agrawal advises stopping and seeking medical advice if you experience: Dizziness, confusion, sweating, shakiness, or slurred speech Severe or persistent nausea and vomiting Abdominal pain that could suggest pancreatitis Feeling unusually impaired despite drinking a small amount Worsened hangovers compared to your normal experience Trouble thinking clearly or coordinating movements Any of these symptoms are a reason to stop drinking and seek medical guidance, Agrawal says